Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

L-purine nucleosides as selective antimalarials.

A M Gero1, G Perrone, D M Brown

  • 1School of Biochemistry and Molecular Genetics, University of New South Wales, Sydney, Australia.

Nucleosides & Nucleotides
|August 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanism of Adefovir, Tenofovir and Entecavir Resistance: Molecular Modeling Studies of How A Novel Anti-HBV Agent (FMCA) Can Overcome the Drug Resistance.

Current medicinal chemistry·2015
Same author

Activity and mechanism of action of HDVD, a novel pyrimidine nucleoside derivative with high levels of selectivity and potency against gammaherpesviruses.

Journal of virology·2013
Same author

Troxacitabine prodrugs for pancreatic cancer.

Nucleosides, nucleotides & nucleic acids·2007
Same author

Purine stress in crithidia: adaptation of a parasite to environmental stress.

Parasitology today (Personal ed.)·2006
Same author

A neuroprotective role of extracellular signal-regulated kinase in N-acetyl-O-methyldopamine-treated hippocampal neurons after exposure to in vitro and in vivo ischemia.

Neuroscience·2003
Same author

Practical synthesis of D-cyclopent-2-enone, the key intermediate of carbocyclic nucleosides.

Nucleosides, nucleotides & nucleic acids·2003

Novel L-nucleosides show promise as anti-malarial drugs. They selectively enter infected red blood cells and are metabolized by a unique malarial enzyme, offering a targeted therapeutic approach.

Area of Science:

  • Medicinal Chemistry
  • Parasitology
  • Drug Discovery

Background:

  • Malaria remains a significant global health burden, necessitating new therapeutic strategies.
  • Existing anti-malarial drugs face challenges like resistance and toxicity.
  • Targeting unique metabolic pathways in Plasmodium falciparum-infected erythrocytes is a promising approach.

Purpose of the Study:

  • To design and develop novel L-nucleoside analogs as potential anti-malarial agents.
  • To investigate the selective uptake and metabolism of L-nucleosides in malaria-infected erythrocytes.
  • To leverage the unique enzymatic activity of malarial adenosine deaminase for drug targeting.

Main Methods:

  • Synthesis of novel L-nucleoside compounds.
  • In vitro assessment of selective uptake by infected erythrocytes.

Related Experiment Videos

  • Enzymatic assays using malarial adenosine deaminase.
  • Evaluation of anti-malarial activity.

    • Main Results:

    • L-nucleosides demonstrated selective entry into malaria-infected erythrocytes.
    • These compounds were effectively metabolized by the malarial adenosine deaminase.
    • The designed L-nucleosides showed potential as anti-malarial therapeutics.

    Conclusions:

    • Novel L-nucleosides represent a promising new class of anti-malarial drug candidates.
    • Their selective targeting and metabolism offer a unique therapeutic advantage.
    • Further development could lead to effective treatments against malaria.